Diamond
M. genitalium, a major sexually transmitted pathogen, remains poorly understood in various aspects of its significance. It is a major cause of male urethritis, and its presence increases the risk of acquiring other infections. For females, untreated M. genitalium infections can lead to pelvic inflammatory disease(PID) and increase the risk of premature birth in pregnant women. In this
session, we will explore the current domestic infection status of M. genitalium and shed light on emerging issues related to treatment and control, particularly focusing on the escalating problem of antimicrobial resistance.
Seegene Inc. is an in vitro diagnostics (IVD) company that owns its original patent technologies including DPO™, TOCE™, MuDT™ and 3 Ct™. With these cutting-edge molecular diagnostic technologies applied to a variety of Seegene PCR products, Seegene has enhanced the sensitivity, specificity, and target coverage per a test to unprecedented levels by providing accurate high-multiplex PCR products that detect genes of multiple pathogens simultaneously per each fluorescence channel. Also, Seegene STARlet-AIOS provides a fully automated workflow, which is compatible with a wide range of Seegene’s syndromic assays. Seegene continues to set new standards in molecular diagnostics through cutting-edge innovations.
Seegene STARlet-AIOS is a compact and complete automation system that maximizes your walk-away time. It is compatible with all Seegene high multiplex real-time PCR assays covering all fields of molecular diagnostics. [Key Features] - Fully automated workflow from extraction to result analysis - Compatibility with Seegene’s symptom-based MDx assays - Field upgrade available with user’s Seegene STARlet & CFX96s - Easy operation/maintenance with modular integration of standalone instruments - Compact size optimized for all hospitals & c-labs
Seegene possesses diverse high multiplex real-time PCR assays that can detect and identify causative pathogens of infectious diseases that show similar symptoms. They cover all fields of molecular diagnostics including respiratory, sexually transmitted, gastrointestinal infections, antimicrobial resistance, and more. Moreover, all Seegene assays are compatible in one streamlined system. [Key Features] - Syndromic tests using high multiplex PCR technology - Covering all fields of molecular diagnostics - Compatibility with Seegene’s automation system, Seegene STARlet-AIOS
Allplex™ MG & AziR Assay and Allplex™ MG & MoxiR Assay are multiplex real-time PCR assays designed to detect Mycoplasma genitalium and 6 mutations related to azithromycin resistance(AziR) or moxifloxacin resistance(MoxiR). [Key Features] - Detecting Mycoplasma genitalium and 6 types of azithromycin resistant mutations simultaneously with a single test (Allplex™ MG & AziR Assay) - Detecting Mycoplasma genitalium and 6 types of moxifloxacin resistant mutations simultaneously with a single test (Allplex™ MG & MoxiR Assay) - 1.5 hours of PCR TAT - Combination test available with Seegene's STI assays - Fully automated workflow from extraction to result analysis using Seegene STARlet-AIOS
Allplex™ HPV HR Detection and Allplex™ HPV28 Detection provides fast and automated HPV testing that enables simultaneous amplification and detection of target nucleic acids of major HPV types. - Detecting and identifying 14 high-risk HPV types simultaneously with a single test (Allplex™ HPV HR Detection) - Detecting and identifying 19 high-risk and 9 low-risk HPV types simultaneously with a single test (Allplex™ HPV28 Detection) - Providing individual Ct values to infer viral load using Seegene 3 Ct™ technology - 1.5 hours of PCR TAT - Fully automated workflow from extraction to result analysis using Seegene STARlet-AIOS
D-
Booth No.